Introduction
Recently, an increasing number of patients have been developing primary and metastatic liver cancers (
1- Simard E.P.
- Ward E.M.
- Siegel R.
- Jemal A.
Cancers with increasing incidence trends in the United States: 1999 through 2008.
). Whereas a liver resection is the most curative therapy to improve the prognosis of such patients, the resection of more than half of the liver is often needed for the complete removal of a hepatic tumor. Although both the surgical techniques and the postoperative management have been improved, liver failure is still one of the most severe complications after major hepatectomy (
2- Jin S.
- Fu Q.
- Wuyun G.
- Wuyun T.
Management of post-hepatectomy complications.
). Portal vein embolization (PVE),
2The abbreviations used are:
PVE
portal vein embolization
PH
partial hepatectomy
PVBL
portal vein branch ligation
H3K4
histone H3 Lys-4
H3K4me3
H3K9me3, and H3K27me3, histone H3 Lys-4, Lys-9, and Lys-27 trimethylation, respectively
RL
regenerating liver
RT-qPCR
RT-quantitative PCR
SAM
S-adenosylmethionine
SAH
S-adenosyl-l-homocysteine
MAT
methionine adenosyltransferase
ChIP-seq
ChIP-sequencing
GO
gene ontology
CHR
cell cycle gene homology region.
a method to stimulate growth of the future remnant liver (not an embolized lobe of the liver), is widely performed preoperatively to prevent postoperative liver failure (
3- Makuuchi M.
- Thai B.L.
- Takayasu K.
- Takayama T.
- Kosuge T.
- Gunvén P.
- Yamazaki S.
- Hasegawa H.
- Ozaki H.
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report.
). However, patients who undergo this procedure often fail to achieve a sufficient increase of the remnant liver volume (
4- van Lienden K.P.
- van den Esschert J.W.
- de Graaf W.
- Bipat S.
- Lameris J.S.
- van Gulik T.M.
- van Delden O.M.
Portal vein embolization before liver resection: a systematic review.
). Therefore, it is essential to understand the mechanism of compensatory hypertrophy of the liver.
The liver is known as the metabolic center of the mammalian body and performs many biological functions, such as the metabolism of amino acids, fatty acids, and carbohydrates, and the detoxification of xenobiotics to maintain the homeostasis of the whole body. In addition, the liver is also known as an organ that possesses the capacity for regeneration. Liver regeneration has fascinated the field of regenerative medicine because many other major organs of the human body lack the capacity to undergo a substantial regeneration in the case of a functional deficiency (
5Repairing organs: lessons from intestine and liver.
). Therefore, the liver has been an attractive organ to investigate the mechanism of tissue regeneration. The method of partial hepatectomy (PH) was described by Higgins and Anderson in 1931 (
6- Higgins G.M.
- Anderson R.M.
Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal.
) and has been widely applied to the study of liver regeneration. Although more and more knowledge has been accumulated about the liver regeneration after PH (
7- Gilgenkrantz H.
- Collin de l'Hortet A.
New insights into liver regeneration.
,
8- Fausto N.
- Campbell J.S.
- Riehle K.J.
Liver regeneration.
9Liver regeneration by stem/progenitor cells.
), this model may only clarify the mechanism of postoperative liver regeneration (
10Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different?.
). On the other hand, the molecular mechanism by which PVE leads to compensatory hypertrophy of the liver remains largely unclear.
The capacity of the liver to regenerate is likely to be encoded as a plasticity of molecular networks within this organ. Whereas several critical regulators of the liver regeneration, such as
NFκ
B and
STAT3, have been reported (
11- Li W.
- Liang X.
- Kellendonk C.
- Poli V.
- Taub R.
STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration.
,
12- Malato Y.
- Sander L.E.
- Liedtke C.
- Al-Masaoudi M.
- Tacke F.
- Trautwein C.
- Beraza N.
Hepatocyte-specific inhibitor-of-κB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration.
), a bird's eye view of the molecular processes is still lacking. Although several studies have utilized massive molecular profiling approaches (
13- White P.
- Brestelli J.E.
- Kaestner K.H.
- Greenbaum L.E.
Identification of transcriptional networks during liver regeneration.
,
14Proteomic analysis of the regenerating liver following 2/3 partial hepatectomy in rats.
), little is still known about how changes in one set of molecules would affect another set of molecules. To gain insight into the molecular mechanism of the liver regeneration after PVE, we utilized the portal vein branch ligation (PVBL) technique in mice, which induces a redistribution of the portal blood flow in a manner similar to PVE (
15- Shirasaki K.
- Taguchi K.
- Unno M.
- Motohashi H.
- Yamamoto M.
NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice.
). By applying a combination of comprehensive analyses of the epigenome, transcriptome, and proteome, we herein show the molecular landscape of liver regeneration after PVBL. We demonstrate that histone H3K4 was trimethylated at the promoter regions of many loci, among which cell-cycle-related genes were transcriptionally up-regulated. By a cistrome analysis of genes guided by the transcriptome and epigenome, FOXM1 was found to be the key transcription factor during liver regeneration, whose induction was accompanied by a new acquisition of H3K4me3 at its promoter region. Our results indicate that liver regeneration involves coordinated alterations in both transcriptional and epigenetic regulations.
Discussion
We herein studied the molecular state of liver regeneration using the mouse PVBL model, which mimics liver regeneration following PVE in humans. We took advantage of the ability to analyze multilayer omics data covering epigenomic, transcriptomic, and proteomic measurements from identical materials. Our principal idea was that one layer of these data sets would be useful to stratify alterations in the other layers, ultimately leading to the identification of critical regulators and/or molecular alterations. This multiomics analysis allowed us to examine the correlations and relationships among multiple omic data and gave us in-depth insights into liver regeneration. Most importantly, by combining the data sets of histone methylation and gene expression, we identified Foxm1 as a critical regulator of liver regeneration. In addition, we found a set of proteins whose abundance was regulated at the post-translational level during liver regeneration. Because our data sets were derived from whole liver lysates, we were unable to examine the cellular interactions between hepatocytes and hepatic non-parenchymal cells (e.g. liver endothelial sinusoid cells and Kupffer cells). Because the hepatocyte occupies ˜90% of the liver volume, we assume that the alterations in the molecular compositions observed in this study largely reflected changes within hepatocytes. Notwithstanding this limitation, our results clarified the molecular state of the regenerating liver following PVBL and established a valuable database to investigate further the mechanism of liver regeneration.
As expected, genes related to cell proliferation and DNA replication were transcriptionally up-regulated. Using a ChIP-seq analysis, we found that the trimethylation of histone H3K4 was strongly induced at the promoter regions of these genes in the regenerating liver. A previous study demonstrated that H3K4 di- and trimethylations were increased in an up-regulated gene during the liver regeneration following PH (
36- Nakagawa T.
- Kajitani T.
- Togo S.
- Masuko N.
- Ohdan H.
- Hishikawa Y.
- Koji T.
- Matsuyama T.
- Ikura T.
- Muramatsu M.
- Ito T.
Deubiquitylation of histone H2A activates transcriptional initiation via trans-histone cross-talk with H3K4 di- and trimethylation.
). However, this previous study did not address the genome-wide distribution of the methylation of H3K4. In addition, our results from the ChIP-seq analysis clearly showed that the induction of H3K4me3 was not restricted to genes that underwent transcriptional up-regulation. Rather, many more genes that were transcriptionally unaltered acquired an increase of H3K4me3 modification compared with those in the livers of the sham-operated group. In other words, not all of the genes that acquired H3K4me3 modification were up-regulated transcriptionally, with only 8.3% of genes significantly up-regulated (-fold change > 2.0). This indicates that the modification with H3K4me3 is not sufficient to activate gene transcription, and other additional factors are needed. One scenario may be that the machinery for the writing of H3K4me3 is rather promiscuous. The increase in methylation potential (SAM/SAH ratio) may also facilitate the methylation reaction. The decrease in the expression of the histone demethylase
Kdm5b may contribute to the pervasive induction of H3K4me3. An interesting question in this context is whether
Kdm5b is involved in the maintenance of liver cell identity and/or quiescence. Another interesting alteration is the reduced expression of
Gnmt, which is expected to lead to a higher flow of SAM into other reactions, including histone methylation. It appears that alterations of metabolic status also facilitate epigenetic remodeling of the regenerating liver.
Our data also suggest that additional proteins, such as DNA-binding transcription factors, may be required to achieve specific gene activation among the vast set of genes that acquired H3K4me3. Consistent with this idea, we found by combining the motif analysis and the microarray analysis that the CHR element and its binding complex FOXM1-MMB play important roles in the regenerating liver. Previous reports have demonstrated that FOXM1 regulates the expression of cell cycle proteins that are essential for reentry of hepatocytes into DNA replication and mitosis after partial hepatectomy (
31- Wang X.
- Kiyokawa H.
- Dennewitz M.B.
- Costa R.H.
The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration.
) and that the FOXM1-MMB complex binds to and activates the cell cycle genes
Ccna2 and
Ccnb1 that regulate the G
2/M phase (
37- Müller G.A.
- Wintsche A.
- Stangner K.
- Prohaska S.J.
- Stadler P.F.
- Engeland K.
The CHR site: definition and genome-wide identification of a cell cycle transcriptional element.
). These genes were significantly up-regulated in our RT-qPCR analysis of regenerating livers, further emphasizing the importance of the FOXM1-MMB complex and the CHR element in the process of liver regeneration. The salient point here is that we identified these factors by the analysis of multiomics data. When we carried out a HOMER analysis using a bulk set of up-regulated genes, CHR was not significantly enriched. Therefore, this method (
i.e. stratifying genes using histone modification patterns) is a powerful tool helping us to investigate the molecular mechanisms of cellular responses. Interestingly, by using the top 50 genes up-regulated during the liver regeneration for a motif analysis, we detected a
de novo CHR motif in the promoter regions of 24 genes. These genes included those with or without the alteration of H3K4me3 modification and were highly enriched in cell-cycle-related terms by a GO analysis. These results raise the possibility that the up-regulation of cell-cycle-related genes through CHR is controlled by both H3K4me3-dependent and -independent mechanisms. It is important to note that H3K4me3 modification at the
Foxm1 promoter region substantially increased during liver regeneration. Therefore, two lines of research will be important in the future: how
Foxm1 is regulated epigenetically in the normal and regenerating liver and whether FOXM1 is involved in the epigenetic regulation of the liver regeneration, especially that of the cell cycle-related genes.
The pervasive induction of H3K4me3 during liver regeneration suggests an interesting strategy for a therapeutic intervention. Among the genes that acquired H3K4me3, one may be able to find genes with the ability to promote cell proliferation. Even if they are not induced during the liver regeneration after PVE, such genes may be ready for the induction of their expression in response to an additional, adequate signal. This is an interesting possibility in light of the fact that
Yap1, which is critical for liver cell proliferation (
38- Kowalik M.A.
- Saliba C.
- Pibiri M.
- Perra A.
- Ledda-Columbano G.M.
- Sarotto I.
- Ghiso E.
- Giordano S.
- Columbano A.
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice.
), was among this set of genes. They may also contain cancer-related genes because regeneration and malignant transformation are phenomena with overlapping molecular events (
39Signaling mechanisms of the epithelial-mesenchymal transition.
). Therefore, this set of genes may be interesting to identify hepatoma-related genes as well. The pervasive induction of H3K4me3 during liver regeneration also raises other interesting questions. For example, why were many of these genes not induced at the transcriptional level? Because H3K4me3 is usually written by the COMPASS complex, which is recruited by RNA polymerase II (
40- Krogan N.J.
- Dover J.
- Wood A.
- Schneider J.
- Heidt J.
- Boateng M.A.
- Dean K.
- Ryan O.W.
- Golshani A.
- Johnston M.
- Greenblatt J.F.
- Shilatifard A.
The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation.
), it will be important to compare binding of RNA polymerase II to the promoter and downstream transcribed regions of these genes.
In this study, we found that genes marked with bivalent histone methylation patterns (H3K4me3 plus H3K27me3) were significantly up-regulated at the transcriptional level during liver regeneration. A GO analysis further revealed that the functions of these bivalent genes were related to the development of multiple organs and tissues. These results are consistent with the previously reported functions of bivalent domains in embryonic stem cells (
24- Bernstein B.E.
- Mikkelsen T.S.
- Xie X.
- Kamal M.
- Huebert D.J.
- Cuff J.
- Fry B.
- Meissner A.
- Wernig M.
- Plath K.
- Jaenisch R.
- Wagschal A.
- Feil R.
- Schreiber S.L.
- Lander E.S.
A bivalent chromatin structure marks key developmental genes in embryonic stem cells.
). In this regard, acquired bivalent domains might enable differentiated cells to dedifferentiate. Considering our observation that a subset of the genes with bivalent histone methylations were up-regulated during the liver regeneration, mature hepatocytes may adopt a quasi-dedifferentiated state following PVBL.
Following PH, several metabolic functions, such as “steroid biosynthesis” and “lipid metabolism,” have been reported to be down-regulated between 2 and 40 h after surgery based on mRNA profiling (
13- White P.
- Brestelli J.E.
- Kaestner K.H.
- Greenbaum L.E.
Identification of transcriptional networks during liver regeneration.
). Our results confirmed that a similar suppression of metabolic functions occurred in the PVBL model. Furthermore, we confirmed this suppression by evaluating the relative protein amounts by a proteomic analysis. Although we did not elucidate the mechanisms underlying the down-regulation of the metabolic functions in the RL, the dedifferentiation of mature hepatocytes may be the reason why functions specific to the liver are down-regulated in the process of regeneration. An interesting candidate that could explain this response is SREBP1 (encoded by
SREBF1), the master regulator of diverse metabolism- and lipid-related genes. The reduction of SREBP1 expression in the regenerating liver may contribute to the aforementioned responses. Interestingly, many of the metabolism-related genes were reduced in their expression while retaining H3K4me3. In a previous report using a partial hepatectomy model, metabolism-related genes including
SREBF1 have been shown to lose H3K9 acetylation at their promoter regions during regeneration (
18- Huang J.
- Schriefer A.E.
- Yang W.
- Cliften P.F.
- Rudnick D.A.
Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
). Therefore, dynamic changes in the combinations of histone modifications and SREBP1 activity may regulate transient repression of these genes during liver regeneration. Further studies will be required to clarify the mechanism of the down-regulation of metabolic functions during the liver regeneration. A detailed analysis of the time point when the suppressed metabolic functions recovered at the proteomic level was beyond the scope of this study. However, it is important to determine such a time point because, clinically, it is desirable for hepatic resection to be performed when the full recovery of metabolic function is achieved. The list of metabolic enzymes may help surgeons to identify markers for such an evaluation.
By comparing the data sets of the transcriptome and the proteome, we also succeeded in identifying proteins with increased levels in the regenerating liver after PVBL without any apparent increase of mRNAs. These proteins may be regulated at the post-transcriptional level. The results using Hepa1 cells and MG132 strongly suggest that a fraction of them are regulated by ubiquitination and degradation. Previous reports have demonstrated that some of these proteins are associated with the functions related to cell proliferation. For example, upon the silencing of
NASP by siRNA, HeLa cells and U2OS cells are unable to replicate their DNA and progress through the cell cycle (
41- Richardson R.T.
- Alekseev O.M.
- Grossman G.
- Widgren E.E.
- Thresher R.
- Wagner E.J.
- Sullivan K.D.
- Marzluff W.F.
- O'Rand M.G.
Nuclear autoantigenic sperm protein (NASP), a linker histone chaperone that is required for cell proliferation.
). In addition, the knocking down of
PIN1 in FaDu cells leads to the inhibition of cell proliferation (
42- Li C.
- Chang D.L.
- Yang Z.
- Qi J.
- Liu R.
- He H.
- Li D.
- Xiao Z.X.
Pin1 modulates p63α protein stability in regulation of cell survival, proliferation and tumor formation.
). Upon PVBL, ubiquitin E3 ligases for these proteins or their interaction may be inactivated, resulting in the accumulation of target proteins. The list of proteins potentially regulated by conditional ubiquitin-mediated degradation may provide another route toward new mechanisms regulating liver regeneration.
In the present study, by analyzing the comprehensive data sets ranging from histone methylation to mRNA expressions and and protein expression profiles, we have unveiled the molecular mechanisms of the liver regeneration following PVBL. The pervasive writing of H3K4me3 may underlie the capacity of the liver to regenerate. We expect this informational resource to be useful to investigate liver regeneration and to provide tools for future biological assays.
Experimental procedures
Animals
Wild-type C57BL/6J mice were purchased from Charles River Laboratories. All of the mice were kept under specific-pathogen-free conditions and were treated according to the Regulations for Animal Experiments and Related Activities at Tohoku University. All experiments involving mice were approved by the institutional animal care and use committee of the Tohoku University Environmental and Safety Committee.
Mouse operation
9–12-week-old male C57BL/6J mice were used. Mice were randomly separated into a PVBL group and a sham operation group. The PVBL technique was described previously (
15- Shirasaki K.
- Taguchi K.
- Unno M.
- Motohashi H.
- Yamamoto M.
NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice.
). In brief, the left branch of the portal vein was ligated with 7-0 braided polyester (Natsume Seisakusho Co. Ltd.) under a microscope. Mice receiving the sham operation underwent the same laparotomy without PVBL. Mice that underwent PVBL were sacrificed at 1, 3, or 7 days after operation, and right lobes were collected as regenerating liver. Sham-operated mice were sacrificed at 3 days after operation. Separated liver tissues were snap-frozen in liquid nitrogen and kept under −80 °C conditions.
Expression profiling by microarray
The procedure of microarray analysis was described previously (
43- Itoh-Nakadai A.
- Hikota R.
- Muto A.
- Kometani K.
- Watanabe-Matsui M.
- Sato Y.
- Kobayashi M.
- Nakamura A.
- Miura Y.
- Yano Y.
- Tashiro S.
- Sun J.
- Ikawa T.
- Ochiai K.
- Kurosaki T.
- Igarashi K.
The transcription repressors Bach2 and Bach1 promote B cell development by repressing the myeloid program.
). Preparation of total RNA from frozen liver tissue was carried out using an RNeasy minikit (Qiagen). Total RNA was labeled with Cyanine 3-CTP by the use of the Low Input Quick Amp Labeling Kit, One-Color (Agilent Technology). A Sureprint G3 mouse GE microarray slide (8 × 60K) was used according to the manufacturer's instructions (Agilent Technology). The data were detected on an Agilent scanner, and the analysis and clustering of genes were performed using the GeneSpringGX (version 12.6) software package (Agilent Technology).
RNA isolation and quantitative RT-PCR
Total RNA was isolated as above and transcribed into cDNA using an RT Omniscript kit (Qiagen) according to the manufacturer's protocol. RT-qPCR was performed with a LightCycler Nano instrument (Roche Applied Science). The following primers were used in this study: Mat1a, forward (5′-TGCTGGATGCCCATCTCAAG-3′) and reverse) (5′-GCATAGCCGAACATCAAACC-3′); Mat2a, forward (5′-CCACGAGGCGTTCATCGAGG-3′) and reverse (5′-AAGTCTTGTAGTCAAAACCT-3′); Kdm5b, forward (5′-AAGAGTTCGCGGACCCCTTC-3′) and reverse (5′-GATCCGCGGGGTGAAATGAA-3′); Foxm1, forward (5′-AAGAATGGCCAACATCCCGA-3′) and reverse (5′-TTGGGCCCCACTCTACCTT-3′); Ccnd1, forward (5′-CAAAATGCCAGAGGCGGATG-3′) and reverse (5′-CATGGAGGGTGGGTTGGAAA-3′); Ccne1, forward (5′-CTTTCTGCAGCGTCATCCTC-3′) and reverse (5′-CCTGTGCCAAGTAGAACGTC-3′); Ccna2, forward (5′-GTGAAGATGCCCTGGCTTTTA-3′) and reverse (5′-AACGTTCACTGGCTTGTCTT-3′); Ccnb1, forward (5′-GTGAGTGACGTAGACGCAGA-3′) and reverse (5′-TCCAGTCACTTCACGACCCT-3′); Inmt, forward (5′-GAAAGAGCCAGGAGCCTACG-3′) and reverse (5′-ACTGTCCTTCTGAGCTTGGC-3′); Hal, forward (5′-CGGCAAGCTGATATTGTGGC-3′) and reverse (5′-ACCGGAATCGGAAAGCAACT-3′); Got1, forward (5′-AACGACAACAGCCTCAACCA-3′) and reverse (5′-AAAGACTGCACCCCTCCAAC-3′); Gcdh, forward (5′-CCTTGTCATGCACCCCATCT-3′) and reverse (5′-AGCCCAGAAGTTCACCCTTG-3′); Cdkn1a, forward (5′-GCAGTCCACAGGATATCCA-3′) and reverse (5′-AGACAACGGCACACTTGCT-3′); Cdkn2C, forward (5′-GTGGGGCATCGGAACCATAA-3′) and reverse (5′-ACCCCATTTGCCTCCATCAG-3′); Cdkn3, forward (5′-TCGCGAGTGAATTGTTCCCA-3′) and reverse (5′-CGTCTTGGATCCCGTAGCTC-3′); Actb, forward (5′-CGTTGACATCCGTAAAGACCTC-3′) and reverse (5′-AGCCACCGATCCACACAGA-3′).
Purification of histone extracts
For analyzing histone modification, histones corresponding to 30 mg of the liver tissue were purified by acid extraction (
44- Tachibana M.
- Matsumura Y.
- Fukuda M.
- Kimura H.
- Shinkai Y.
G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription.
). The extracts were separated by SDS-PAGE on 15% gel, and modified histones were detected by immunoblotting analysis as described above.
Immunoblotting analysis
Whole-cell extracts were prepared from the frozen liver tissue as described previously (
22- Katoh Y.
- Ikura T.
- Hoshikawa Y.
- Tashiro S.
- Ito T.
- Ohta M.
- Kera Y.
- Noda T.
- Igarashi K.
Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein.
). The extracts were separated by SDS-PAGE on 4–20% gel. Following SDS-PAGE, the proteins were transferred to a PVDF membrane (Millipore, Billerica, MA). The membranes were blocked for 1 h in blocking buffer (3% skimmed milk, 0.05% Tween 20 in TBS) and subsequently incubated with primary and secondary antibodies in the blocking buffer for 8 and 0.5 h, respectively. To detect immunoreactive proteins, we used SuperSignal West Pico (Thermo Fisher Scientific, San Jose, CA).
Quantification of methionine, SAM, and SAH concentrations
All chemical reagents used for quantification of the indicated metabolites were purchased from Sigma-Aldrich unless otherwise noted. Deuterium-labeled S-adenosyl-l-methionine (d3-SAM) was purchased from C/D/N isotopes, and 13C5-SAH was purchased from Toronto Research Chemicals. Stock solutions of standard SAM, SAH, methionine, and their derivatives labeled with stable isotopes were prepared by dissolving in 0.1% formic acid. The calibration mixtures in the concentration range of 12.5–1600 nm, including a 50 nm concentration of the respective molecules with stable isotopes, were prepared in 50% methanol containing 0.1% formic acid by dilution of stock solutions. The calibration curves were obtained by the peak area ratio (analyte/internal standard).
To measure the level of metabolites, mouse livers were quickly excised, weighted, and frozen in liquid nitrogen. The frozen aliquots were homogenized in 150 μl of 50% cold methanol with a BioMasher II homogenizer (Nippi, Japan). The homogenate was diluted with 150 μl of 50% cold methanol and centrifuged at 20,000 × g for 5 min at 0 °C. The supernatant (200 μl) was collected and mixed with 40 μl of chloroform. The aqueous (160-μl) layer was collected by centrifugation at 20,000 × g for 5 min at 0 °C and mixed with 40 μl of internal standard solution containing 2.5 μm d3-SAM, 13C5-SAH, and 13Cd3-Met dissolved in 0.1% formic acid. After centrifugation, 140 μl of supernatant was lyophilized and resuspended in 50% methanol containing 0.1% formic acid. The supernatant was diluted 10-fold with H2O and passed through a filter (pore size, 0.2 μm; YMC Co., Kyoto, Japan). Subsequently, 5 μl of the filtered solution was injected into the MS/MS system.
The HPLC-MS/MS system consisted of a NANOSPACE SI-II LC system (Shiseido, Tokyo, Japan) coupled with a Q-Exactive quadrupole orbitrap mass spectrometer equipped with a heated electrospray ionization source (Thermo Fisher Scientific). The metabolites were separated by hydrophilic interaction chromatography with a 4.6-mm internal diameter × 10-cm Amide XBridge column (Waters). Mobile phase A was composed of 10 mm ammonium hydroxide and 10 mm ammonium acetate in 95:5 (v/v) H2O/CH3CN, and mobile phase B was 100% CH3CN. A gradient started from 85% B to 35% B from 0 to 3 min; 35% B to 0% B from 3 to 12 min; 0% B from 12 to 17 min; 0 to 85% B from 17–18 min; and 85% B held for 7 min to re-equilibrate the column. A divert valve was used to divert the LC effluent to the waste during the first 3 min, and the range between 11 and 21 min of the chromatographic was run to prevent source contamination by salts and other compounds. The flow rate was 300 μl/min. The optimized ion source parameters were as follows: sheath gas flow rate, 20 arbitrary units; spray voltage, 3 kV; capillary temperature, 400 °C; heater temperature, 40 °C. The detection of metabolites was carried out using positive ion mode and target MS/MS (t-MS2) mode at a resolution 35,000 and normalized collision energy 20. The following MS transitions were used to measure the indicated metabolites: SAM (m/z 399.14 → 250.09), d3-SAM (m/z 402.16 → 250.09), SAH (m/z 385.13 → 136.06), 13C5-SAH (m/z 390.15 → 136.06), methionine (m/z 150.06 → 104.05), and 13Cd3-Met (m/z 154.08 → 108.08). The HPLC-MS/MS system was controlled by XCalibur software (Thermo Fisher Scientific), and peak areas for each metabolite at the SRM transitions were integrated using the same software. Absolute concentrations of cellular metabolites were normalized to the weight of excised liver.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was performed as described previously (
45- Kera Y.
- Katoh Y.
- Ohta M.
- Matsumoto M.
- Takano-Yamamoto T.
- Igarashi K.
Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus.
), with a modification. After thawing, regenerating liver and sham liver were roughly homogenized with a BioMasher II homogenizer (Nippi, Japan) in ice-cold PBS and were cross-linked for 10 min in 1% formaldehyde at 25 °C, followed by quenching for 5 min at 25 °C with 125 m
m glycine. The homogenates were then washed three times with ice-cold PBS and lysed for 10 min at 4 °C in 1 ml of lysis buffer (50 m
m Tris-HCl, pH 8.0, 5 m
m EDTA, and 1% SDS) with rotation. Lysates were centrifuged, and precipitates were suspended in 200 μl of lysis buffer. The cross-linked chromatin was sheared with a Bioruptor sonicator (CosmoBio), and chromatin was quantified with a Nano Drop UV spectrometer. A total of 30 μg of chromatin was diluted 10-fold in dilution buffer (20 m
m Tris-HCl, pH 8.0, 2 m
m EDTA, 150 m
m NaCl, 1% Triton X-100). After immunoprecipitation with anti-H3K4me3, anti-H3K27me3, or anti-rabbit IgG antibodies at 4 °C overnight, Dynabeads Protein A and Protein G (Veritas) were added and rotated at 4 °C for 2 h. The immunoprecipitated chromatin fragments bound to magnetic beads were washed with the following buffers: low-salt buffer (0.1% SDS, 20 m
m Tris-HCl, pH 8.0, 2 m
m EDTA, 150 m
m NaCl), high-salt buffer (0.1% SDS, 20 m
m Tris-HCl, pH 8.0, 2 m
m EDTA, 500 m
m NaCl), and LiCl buffer (1% Nonidet P-40, 250 m
m LiCl, 10 m
m Tris-HCl, pH 8.0, 1 m
m EDTA). The immunoprecipitated chromatin fragments were eluted from the beads by vortexing for 5 min at room temperature in 120 μl of elution buffer (100 m
m NaHCO
3, 1% SDS) and were released from formaldehyde fixation by overnight incubation at 65 °C, followed by incubation for 1 h at 55 °C in the presence of RNase and for 2 h in the presence of proteinase K. Genomic DNA was purified using the DNA Clean & Concentrater Kit according to the manufacturer's protocol (Zymo Research). We performed biological triplicates for the ChIP of H3K4me3 and H3K27me3 with both the sham and PVBL groups.
ChIP-seq and data analysis
The procedure of ChIP-seq analysis was described previously (
46- Hosogane M.
- Funayama R.
- Nishida Y.
- Nagashima T.
- Nakayama K.
Ras-induced changes in H3K27me3 occur after those in transcriptional activity.
). ChIP-seq libraries were prepared from ˜10 ng each of ChIP and input DNA with the use of an Ovation Ultralow DR Multiplex System (NuGEN, catalog no. 0330-32, 0331-32). Two rapid-mode flow cells of an Illumina HiSeq 2500 were used for this analysis. Libraries were clonally amplified in the flow cells and sequenced with the use of HiSeq Control Software version 2.2.38 (Illumina) and a 51- nucleotide paired-end sequence. Image analysis and base calling were performed using real-time analysis software (RTA version 1.18.61, Illumina).
Sequenced reads were mapped to the mouse genome (UCSC mm9) with the use of bwa (version 0.7.10). Unique reads mapped to a single genomic location were called peaks using the MACS2 software (version 2.1.0) for H3K4me3 marks, and sequence reads for input DNA from mice with PVBL or sham operations were used as a control. Sequencing was performed with biological duplicates. Heat maps depicting the patterns of histone methylation were illustrated using the ngs.plot algorithm (version 2.47.1) (
47- Shen L.
- Shao N.
- Liu X.
- Nestler E.
ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases.
).
Cell culture
Mouse hepatoma Hepa1c1c7 cells (Hepa1) were maintained in Dulbecco's modified Eagle's medium, supplemented with 10% FBS, penicillin (100 units/ml), streptomycin (0.1 mg/ml), and 4500 mg/L glutamine.
RNA interference
For knockdown of Foxm1, Hepa1 cells (5 × 106 cells) were electroporated with 6 μl of 20 μm stock Stealth RNAi duplexes using the Nucleofector and Nucleofector solution kit V (VCA-1003, Amaxa Biosystems). The sequence of the Stealth RNAiTM used for knockdown of Foxm1 was 5′-ACCCAAGGUGUUGCUAUCCAGUGAA-3′. Stealth RNAi siRNA negative control (Invitrogen) was used as the negative control.
Cell proliferation assay
Twenty-four hours after transfection with siRNAs, Hepa1 cells were seeded at 5 × 103 cells/well in 96-well flat-bottom plates. Cell proliferation was analyzed using a Cell Counting Kit-8 (Dojindo) according to the manufacturer's protocol. The absorbance values at 450 nm were measured using a microplate reader just after seeding the well and at 24, 48, and 72 h.
Nano-HPLC/MS/MS analysis for proteomics
The dried peptide extracts (30 μg) and 100 fmol of internal control probes (Pierce Retention Time Calibration Mixture, Thermo Scientific) were dissolved together in 80 μl of sample solution (5% acetonitrile and 0.1% trifluoroacetic acid (TFA)). Each sample (1.25 μg/5 μl) was injected into a EasynLC-1000 system (Thermo) with EASY-Spray column (25-cm length × C18 diameter 75 μm, Thermo). Peptides were eluted with a 180-min gradient of 4–25% solvent B (0.1% (v/v) formic acid in acetonitrile) in solvent A (0.1% (v/v) formic acid in water) at a flow rate of 300–400 nl/min. Peptides were then analyzed by a Fusion mass spectrometer (Thermo Fisher Scientific) using a nanospray source. High-resolution full-scan MS spectra (from m/z 400 to 2,000) were acquired in the orbitrap with resolution (r = 120,000 at m/z 400) and lockmass enabled (m/z at 445.12003 and 391.28429), followed by MS/MS fragmentation of the most intense ions for 3 s in the linear ion trap with collisionally activated dissociation energy of 35%. The exclusion duration for the data-dependent scan was 0 s, and the isolation window was set at 10.0 m/z.
The MS/MS data were analyzed by sequence alignment using variable and static modifications by Mascot and Sequest algorithms. UniProt was used as a protein database. The specific parameters for protein sequence database searching included oxidation (M), deamination (N, Q), acetylation (N-term.), and pyroglutamation (E) as variable modifications and carbamidomethylation (C) as a static modification. Other parameters used in data analysis were as follows: two allowed missing cleavages and a mass error of 10 ppm for precursor ions and 0.8 Da for fragment ions. Charge states of +2 to +4 were considered for parent ions. When multiple spectra were assigned to a peptide, only the spectrum with the highest Mascot score was selected for manual analysis. All peptides identified with a Mascot peptide score of > 20 were manually examined using rules described previously (
48- Chen Y.
- Kwon S.W.
- Kim S.C.
- Zhao Y.
Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra.
). The relative quantification of proteins was carried out as described previously (
49- Silva J.C.
- Gorenstein M.V.
- Li G.Z.
- Vissers J.P.
- Geromanos S.J.
Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition.
). Briefly, the semiquantification of each protein was calculated from the average MS signal area of the three most intense peptides and normalized by semiquantitative values of internal control probes.
Antibodies
For immunoblotting and ChIP analysis, we used the following antibodies: anti-MATI/III (sc-28029, Santa Cruz Biotechnology, Inc.), anti-GAPDH (ab8245, Abcam), anti-trimethylated histone H3 Lys-4 (ab8580, Abcam), anti-trimethylated histone H3K9 (ab8898, Abcam), anti-trimethylated histone H3 Lys-27 (07-449, Millipore), anti-histone H3 (ab1791, Abcam), anti-FOXM1 (sc-502, Santa Cruz Biotechnology), anti-STAT3 (06-596, Millipore), anti-phospho-STAT3 (Tyr-705) (catalog no. 9145, Cell Signaling Technology), and anti-rabbit IgG (02-6102, Invitrogen). Anti-MATIIα antibody was raised by immunizing rabbits with purified recombinant MATIIα (His6-tagged mouse MATIIα) expressed in Escherichia coli.
Statistical analysis
Statistical analysis was performed with Student's t test or the Mann-Whitney U test, using the open-source statistical programing environment R.
Author contributions
Y. S., Y. K., M. U., and K. I. were responsible for conceptualization; Y. S., Y. K., M. S., A. I.-N., and M. E. were responsible for methodology; Y. S., M. M., and K. I. were responsible for formal analysis; Y. S., Y. K., M. S., M. E., R. F., and K. N. were responsible for the investigation; M. M. was responsible for informatics; Y. S. wrote the original draft; Y. S. and K. I. were responsible for writing review and editing; and M. M., Y. K., and K. I. supervised the work.
Acknowledgments
We thank Daniel R. Sharda (Olivet Nazarene University, Bourbonnais, IL), Tapas K. Kundu (Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore, India), Hideki Katagiri (Tohoku University Graduate School of Medicine, Sendai, Japan), Takuma Shiraki (Kindai University, Higashiosaka, Japan), and Satoshi Nishizuka (Iwate Medical University School of Medicine) for helpful discussions. We are grateful for stimulating discussions with Igarashi laboratory members, and we thank Akihiko Muto for help with the ChIP experiment. We also thank Unno laboratory members for discussion. We thank M. Tsuda, M. Kikuchi, M. Nakagawa, and K. Kuroda for technical assistance. We also acknowledge the technical support of the Biomedical Research Core of Tohoku University Graduate School of Medicine.
Article info
Publication history
Published online: March 16, 2017
Received in revised form:
February 28,
2017
Received:
December 29,
2016
Edited by John M. Denu
Footnotes
This work was supported by Grants-in-Aid 15H02506, 25670156, 24390066, and 23116003 and the Network Medicine Global COE Program from the Ministry of Education, Culture, Sport, Science and Technology of Japan and AMED-CREST from the Japan Agency for Medical Research and Development. Additional initiative supports were from the Uehara Foundation, Takeda Foundation, and Astellas Foundation for Research on Metabolic Disorders. Restoration of the laboratory from the damage due to the 2011 Tohoku earthquake was provided in part by the Astellas Foundation for Research on Metabolic Disorders, the Banyu Foundation, the Naito Foundation, A. Miyazaki, and A. Iida. The authors declare that they have no conflicts of interest with the contents of this article.
Copyright
© 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.